SYNERGY™ XD H7493941824270Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY XD (65)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 2
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 08714729980902), received between Dec 13, 2021 and Jan 5, 2026 — classified as 2 deaths, 2 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Break” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break3
- Difficult to Remove3
- Material Rupture2
- Adverse Event Without Identified Device or Use Problem1
- Failure to Advance1
- Inflation Problem1
- Material Deformation1
- Nonstandard Device1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- Cardiac Arrest2
- Chest Pain2
- Respiratory Arrest2
- Discomfort1
- Insufficient Information1
- Obstruction/Occlusion1
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 5, 2026Nonstandard Device; Difficult to Remove; Failure to Advance
IT WAS REPORTED THAT REMOVAL DIFFICULTY OCCURRED. A 2.75 X 24MM SYNERGY? XD DRUG-ELUTING WAS ADVANCED FOR TREATMENT. HOWEVER, THE DEVICE FAILED TO CROSS THE LESION, AND DIFFICULTY WAS ENCOUNTERED DURING REMOVAL. THE PROCEDURE WAS SUBSEQUENTLY COMPLETED USING A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23965384 ↗DeathApr 15, 2025Break; Difficult to Remove; Break; Difficult to Remove
IT WAS REPORTED THAT THE PATIENT DIED. THE PATIENT UNDERWENT PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH THE DEPLOYMENT OF A 2.75 X 24 MM SYNERGY XD DRUG-ELUTING STENT. DURING THE PROCEDURE, THE BALLOON SHAFT FRACTURED PROXIMAL TO THE MID-LEFT ANTERIOR DESCENDING (LAD) ARTERY POST-DEPLOYMENT. ALTHOUGH THE STENT WAS SUCCESSFULLY DEPLOYED, THE BALLOON COULD NOT BE REMOVED. THE FRACTURED DEVICE WAS EXTRACTED USING A SNARE. AFTER THE REMOVAL, THE PATIENTS CONDITION DETERIORATED RAPIDLY. A FULL CODE WAS INITIATED IN AN ATTEMPT TO STABILIZE THE PATIENT, BUT DESPITE ALL RESUSCITATIVE EFFORTS, THE PATIENT PASSED AWAY.
Patient problems: Cardiac Arrest; Chest Pain; Insufficient Information; Respiratory Arrest
MAUDE report 21840294 ↗DeathApr 8, 2025Break; Physical Resistance/Sticking
PATIENT ARRIVED IN CATH LAB FOR A CARDIAC CATHETERIZATION. PROCEDURE BEGAN WITH ACCESS TO THE RIGHT GROIN AND DIAGNOSTIC IMAGING SHOWED A LESION IN THE PROXIMAL LAD. LESION WAS PREDILATED WITH A 2.0 X 20MM TAKERU BALLOON. A 2.75 X 24MM SYNERGY DES WAS THEN PASSED DOWN AND ACROSS THE LESION. STENT DEPLOYED TO 20 ATMS. UPON ATTEMPTED REMOVAL OF DELIVERY CATHETER, RESISTANCE WAS MET. CATHETER THEN RELEASED AND WAS REMOVED WHERE IT WAS NOTED THE CATHETER WAS BROKEN. ANGIOGRAPHY SHOWED THE BALLOON MARKERS WERE STILL IN THE VESSEL. PATIENT BEGAN TO COMPLAIN OF CHEST DISCOMFORT AND PATIENT WAS INTUBATED. VASCULAR SURGEON WAS CALLED TO ASSIST AND SUCCESSFULLY RETRIEVED BROKEN PIECE FROM BODY. PATIENT DISTRESS CONTINUED TO ESCALATE. CARDIAC AND RESPIRATORY ARREST SHORTLY FOLLOWED. CPR BEGAN AND ATTEMPTS TO PLACE AN IMPELLA DEVICE UNSUCCESSFUL. PATIENT EXPIRED IN CATH LAB.
Patient problems: Cardiac Arrest; Chest Pain; Discomfort; Respiratory Arrest
MAUDE report 21797169 ↗InjuryDec 6, 2022Inflation Problem; Difficult to Remove; Inflation Problem; Difficult to Remove
IT WAS REPORTED THAT PATIENT VESSEL OBSTRUCTION OCCURRED. A PROCEDURE WAS BEING PERFORMED USING A SYNERGY XD MR US 2.75 X 24MM DEVICE FOR TREATMENT. DURING THE PROCEDURE WHILE INSIDE THE PATIENT, IT WAS NOTED THAT THE BALLOON WAS ONLY ABLE TO INFLATE ABOUT HALFWAY. THE STENT WAS ABLE TO DEPLOY ON THE PROXIMAL END, BUT REMAINED ATTACHED TO THE BALLOON ON THE DISTAL END. UPON CLOSER INSPECTION, IT WAS NOTICED THAT THE STRUTS OF THE STENT WERE STUCK ON THE BALLOON. THE INDEFLATOR HAD LOST PRESSURE AND WAS NOTED TO BE SPINNING. UPON TRYING TO REMOVE THE STENT CATHETER USING MULTIPLE WAYS, INCLUDING INSERTING A NON-BOSTON SCIENTIFIC GUIDE EXTENSION CATHETER OVER THE BALLOON AND USING MANUAL FORCE TO DISLODGE THE STRUTS FROM THE BALLOON, THE DIAGONAL BRANCH SHUT DOWN AND LOST FLOW. THE PATIENT WAS THEN SENT TO SURGERY AND THE STENT WAS SUCCESSFULLY REMOVED.
Patient problems: Obstruction/Occlusion
MAUDE report 15925632 ↗MalfunctionNov 25, 2022Material Rupture; Material Rupture
IT WAS REPORTED VIA USER/FACILITY MEDWATCH # 5113226 THAT BALLOON RUPTURE OCCURRED. A 2.75 X 24MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING PROCEDURE, THE STENT BALLOON RUPTURED. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15866695 ↗InjuryNov 10, 2022Material Rupture
STENT BALLOON RUPTURE DURING BALLOON ANGIOPLASTY. FDA SAFETY REPORT ID # (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15789372 ↗MalfunctionJun 2, 2022Material Deformation; Adverse Event Without Identified Device or Use Problem; Material Deformation; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. A 2.75 X 24MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED FOR TREATMENT. HOWEVER, DURING PREPARATION, IT WAS NOTED THAT THE TIP OF THE STENT WAS DAMAGED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14579309 ↗MalfunctionDec 13, 2021Break; Break
IT WAS REPORTED THAT A SHAFT BREAK OCCURRED. A PERCUTANEOUS CORONARY INTERVENTION WAS BEING PERFORMED. THIS 2.75X24MM SYNERGY XD WAS SELECTED, DURING INTRODUCTION THE SHAFT FRACTURED OUTSIDE THE BODY 10 INCHES FROM THE HUB. THE DEVICE WAS REMOVED FROM THE PATIENT, NOTHING WAS LEFT INSIDE THE BODY. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12983442 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page